Canopy Growth - Common Shares (CGC) closed at $0.61 on November 11, 2026, up 2.2% from the previous close, on volume of 2,183,166 shares (30-day average 2,645,548).
Data as of November 11, 2026.
11-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 28, 2026 | Diagonal Call Spread | 06-Nov-26 : 15-Jan-271 : 1.5 C | 860 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 11, 2026. See the 10 largest for 30, 60 and 90 days
TipRanks (Mon, 9-Nov 6:30 AM ET)
Business Wire (Fri, 6-Nov 7:00 AM ET)
Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
Business Wire (Mon, 26-Oct 7:30 AM ET)
Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026
Business Wire (Thu, 22-Oct 7:00 AM ET)
Business Wire (Tue, 13-Oct 7:30 AM ET)
Canopy Growth Appoints Sebastian Blte as Country Manager for Germany
Business Wire (Mon, 28-Sep 7:30 AM ET)
Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum
Business Wire (Fri, 25-Sep 2:00 PM ET)
Business Wire (Wed, 23-Sep 7:30 AM ET)
Canopy Growth Expands European Medical Cannabis Supply Into the UK
Business Wire (Tue, 22-Sep 7:30 AM ET)
Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline
Business Wire (Mon, 14-Sep 7:30 AM ET)
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
Canopy Growth - Common Shares trades on the NASDAQ stock market under the symbol CGC.
As of November 11, 2026, CGC stock price climbed to $0.61 with 2,183,166 million shares trading.
CGC has a beta of 1.40, meaning it tends to be more sensitive to market movements. CGC has a correlation of 0.08 to the broad based SPY ETF.
CGC has a market cap of $256.13 million. This is considered a Small Cap stock.
Last quarter Canopy Growth - Common Shares reported $58 million in Revenue and -$.07 earnings per share. This fell short of revenue expectation by $-971,000 and missed earnings estimates by -$.04.
In the last 3 years, CGC traded as high as $14.92 and as low as $.58.
The top ETF exchange traded funds that CGC belongs to (by Net Assets): MJ, YOLO.
CGC has underperformed the market in the last year with a price return of -49.6% while the SPY ETF gained +12.4%. CGC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -39.5% and -10.0%, respectively, while the SPY returned -1.1% and -1.6%, respectively.
CGC support price is $.57 and resistance is $.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CGC shares will trade within this expected range on the day.
